The binding of doxorubicin to large unilamellar vesicles consisting of cardiolipin or other anionic phospholipids was analyzed in terms of the local drug concentration at the membrane surface, according to the Gouy-Chapman theory. The analysis suggests strong positive binding cooperativity. Part of the drug binds in the uncharged form. The affinity for cardiolipin and other anionic phospholipids is comparable. A binding level of 0.5 doxorubicin per lipid-phosphorus is reached when the local concentration of free doxorubicin monomer-equivalents at the membrane surface is about 0.2–0.7 mM. This contrasts with earlier findings indicating a 300–1000 fold higher affinity for cardiolipin. The present analysis provides an explanation for this apparent discrepancy.
Skip Nav Destination
Article navigation
Research Article|
October 01 1991
Binding of doxorubicin to cardiolipin as compared to other anionic phospholipids—An evaluation of electrostatic effects
Frits A. de Wolf
Frits A. de Wolf
1Institute of Molecular Biology and Medical Biotechnology and Centre for Biomembranes and Lipid Enzymology, State University of Utrecht, Padualaan 8, 3584 CH Utrecht, The Netherlands
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
September 02 1991
Online ISSN: 1573-4935
Print ISSN: 0144-8463
© 1991 Plenum Publishing Corporation
1991
Biosci Rep (1991) 11 (5): 275–284.
Article history
Received:
September 02 1991
Citation
Frits A. de Wolf; Binding of doxorubicin to cardiolipin as compared to other anionic phospholipids—An evaluation of electrostatic effects. Biosci Rep 1 October 1991; 11 (5): 275–284. doi: https://doi.org/10.1007/BF01127503
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |